KNSA vs UBER · P/E 53, rev $423.2M vs P/E 18, rev $52.02B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported KNSA revenue for 2024-12-31 was $423.2M. Net income was -$43.2M. Revenue was up 56.6% from 2023-12-31 to 2024-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the KNSA and UBER stock pages for the full models.
Not investment advice.